Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
910.00    80.00 (9.64%)
Bid:
907.20
Ask:
908.80
Spread: 1.60 (0.176%)
Market Cap: £9.10b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Half-year Report

29 Nov 2021 14:38

RNS Number : 9227T
Wise PLC
29 November 2021
 

Wise plc

29 November 2021

 

Release of unaudited historic financial information

 

Wise is today releasing selected historic consolidated financial statements on an unaudited half yearly basis for the year ended 31 March 2021.

 

 

Enquiries

Martin Adams - Head of Owner Relations

martin.adams@wise.com

 

 

Condensed consolidated statement of comprehensive income (unaudited)

 

 

Year ended

Half-year ended

Half-year ended

£m (unless otherwise noted)

31 March 2021

30 September 2020

31 March 2021

Revenue

421.0

192.2

228.8

Cost of sales

(151.7)

(71.8)

(79.9)

Net credit losses on financial assets

(8.8)

(1.2)

(7.6)

Gross profit

260.5

119.2

141.3

Administrative expenses

(217.5)

(97.6)

(119.9)

Interest income from investments and operating assets

1.9

1.0

0.9

Interest expense from operating assets

(3.8)

(1.6)

(2.2)

Other income

3.8

1.1

2.7

Operating profit

44.9

22.1

22.8

Finance expense

(3.8)

(2.1)

(1.7)

Profit before tax

41.1

20.0

21.1

Income tax expense

(10.2)

(5.4)

(4.8)

Profit for the period

30.9

14.6

16.3

Other comprehensive income

Items that may be reclassified to profit or loss:

Fair value (loss)/gain on investments

(3.0)

0.2

(3.2)

Currency translation differences

(3.8)

0.3

(4.1)

Total other comprehensive (loss)/income

(6.8)

0.5

(7.3)

Total comprehensive income for the period

24.1

15.1

9.0

 

 

 

Condensed consolidated statement of financial position (unaudited)

 

 

As at 31 March

As at 30 September

As at 31 March

£m

2020

2020

2021

Non-current assets

Deferred tax assets

32.0

38.7

56.7

Property, plant and equipment

19.1

16.7

24.0

Intangible assets

21.3

24.4

27.5

Trade and other receivables

7.6

8.3

15.1

Total non-current assets

80.0

88.1

123.3

Current assets

Current tax assets

2.1

1.7

1.1

Trade and other receivables

102.6

89.2

81.3

Short-term financial investments

114.1

289.3

737.5

Cash and cash equivalents

2,077.6

2,872.1

3,358.6

Total current assets

2,296.4

3,252.3

4,178.5

Total assets

2,376.4

3,340.4

4,301.8

Non-current liabilities

Deferred tax liabilities

-

-

2.0

Non-current borrowings

59.6

9.0

95.2

Non-current trade and other payables

7.4

9.5

22.6

Total non-current liabilities

67.0

18.5

119.8

Current liabilities

Borrowings

4.2

28.3

3.5

Current tax liabilities

0.7

0.8

2.0

Trade and other payables

2,107.7

3,051.2

3,891.2

Total current liabilities

2,112.6

3,080.3

3,896.7

Total liabilities

2,179.6

3,098.8

4,016.5

Equity

Share capital

9.4

9.4

9.4

Equity merger reserve

111.1

112.0

(8.0)

Share-based payment reserves

63.8

90.0

124.5

Own shares reserve

-

-

-

Other reserves

2.3

2.5

(0.7)

Retained earnings

8.9

26.1

162.6

Currency translation differences

1.3

1.6

(2.5)

Total equity

196.8

241.6

285.3

Total liabilities and equity

2,376.4

3,340.4

4,301.8

 

 

Condensed consolidated statement of cash flows (unaudited)

 

 

 

£m

Year ended

Half-year ended

Half-year ended

31 March 2021

30 September 2020

31 March 2021

Cash flows from operating activities

Cash generated from operations

2,076.3

1,012.0

1,064.3

Interest received

7.6

2.7

4.9

Interest expense paid

(6.0)

(2.7)

(3.3)

Corporate income tax paid

(4.0)

(0.8)

(3.2)

Net cash generated from operating activities

2,073.9

1,011.2

1,062.7

Cash flows from investing activities

Payments for property, plant and equipment

(2.3)

(1.1)

(1.2)

Payment for intangible assets

(20.9)

(10.1)

(10.8)

Payments for financial assets at FVOCI

(723.9)

(222.7)

(501.2)

Proceeds from sale and maturity of financial assets at FVOCI

75.3

41.1

34.2

Net cash used in investing activities

(671.8)

(192.8)

(479.0)

Cash flows from financing activities

Proceeds from issues of shares and other equity

0.9

0.9

-

Proceeds from borrowings

118.6

25.0

93.6

Repayments of borrowings

(90.0)

(50.0)

(40.0)

Payments for lease liabilities

(4.7)

(2.4)

(2.3)

Net cash generated from financing activities

24.8

(26.5)

51.3

Net increase in cash and cash equivalents

1,426.9

791.9

635.0

Cash and cash equivalents at beginning of the period

2,077.6

2,077.6

2,872.1

Effects of exchange rate changes on cash and cash equivalents

(145.9)

2.6

(148.5)

Cash and cash equivalents at end of the period

3,358.6

2,872.1

3,358.6

 

 

Condensed consolidated statement of changes in equity (unaudited)

 

 

£m

Share capital

Equity merger reserve

Share-based payment reserves

Own shares reserve

Other reserves

Retained earnings

Currency translation differences

Total equity

At 1 April 2020

9.4

111.1

63.8

-

2.3

8.9

1.3

196.8

Profit for the period

-

-

-

-

-

14.6

-

14.6

Fair value gain on investments

-

-

-

-

0.2

-

-

0.2

Foreign currency translation differences

-

-

-

-

-

-

0.3

0.3

Total comprehensive income for the period

-

-

-

-

0.2

14.6

0.3

15.1

Share-based employee compensation expense

-

-

18.0

-

-

-

-

18.0

Deferred tax on share-based compensation

-

-

10.8

-

-

-

-

10.8

Share options exercises

-

0.9

(2.6)

-

-

2.6

-

0.9

At 30 September 2020

9.4

112.0

90.0

-

2.5

26.1

1.6

241.6

Profit for the period

-

-

-

-

-

16.3

-

16.3

Fair value loss on investments

-

-

-

-

(3.2)

-

-

(3.2)

Foreign currency translation differences

-

-

-

-

-

-

(4.1)

(4.1)

Total comprehensive income for the period

-

-

-

-

(3.2)

16.3

(4.1)

9.0

Reduction of share capital

-

(120.0)

-

-

-

120.0

-

-

Share-based employee compensation expense

-

-

18.9

-

-

-

-

18.9

Deferred tax on share-based compensation

-

-

15.8

-

-

-

-

15.8

Share options exercises

-

-

(0.2)

-

-

0.2

-

-

At 31 March 2021

9.4

(8.0)

124.5

-

(0.7)

162.6

(2.5)

285.3

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFVSLSLAFIL
Date   Source Headline
13th Sep 202210:21 amRNSHolding(s) in Company
12th Sep 20223:39 pmRNSHolding(s) in Company
9th Sep 20227:00 amRNSHolding(s) in Company
8th Sep 20227:00 amRNSTotal Voting Rights
6th Sep 20229:41 amRNSPDMR Shareholding
31st Aug 202211:31 amRNSTotal Voting Rights
15th Aug 202211:00 amRNSNotice of AGM
4th Aug 202212:01 pmRNSDirector/PDMR Shareholding
1st Aug 20224:50 pmRNSHolding(s) in Company
1st Aug 202210:02 amRNSTotal Voting Rights
25th Jul 202210:39 amRNSPDMR Shareholding
20th Jul 20222:12 pmRNSHolding(s) in Company
20th Jul 202211:43 amRNSPDMR Shareholding
19th Jul 20227:00 amRNSWise Plc Q1 FY23 Trading Update
6th Jul 20221:00 pmRNS2022 Annual Report & notice Q1 FY23 trading update
1st Jul 20223:57 pmRNSTotal Voting Rights
28th Jun 20227:00 amRNSWise plc FY22 results for year ended 31 March 2022
27th Jun 20227:00 amRNSFCA Investigation
31st May 20224:25 pmRNSTotal Voting Rights
25th May 20222:11 pmRNSDirector/PDMR Shareholding
17th May 20221:57 pmRNSCFO Update
6th May 20223:46 pmRNSQ1 2022 Mission Update
5th May 202212:46 pmRNSDirector/PDMR Shareholding
20th Apr 20223:12 pmRNSDirector/PDMR Shareholding
20th Apr 20223:11 pmRNSDirector/PDMR Shareholding
5th Apr 202212:19 pmRNSDirector/PDMR Shareholding
1st Apr 20229:00 amRNSChange of Remuneration Committee Chair
18th Mar 202211:51 amRNSChanges to Committee Composition
24th Feb 20223:54 pmRNSAppointment of Interim CFO
24th Feb 20223:02 pmRNSDirectorate Change
2nd Feb 20221:21 pmRNSDirector/PDMR Shareholding
28th Jan 20224:47 pmRNSTotal Voting Rights
24th Jan 20229:20 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSQ3 FY2022 Trading Update
4th Jan 202210:20 amRNSTotal Voting Rights
23rd Dec 20211:34 pmRNSDirector/PDMR Shareholding
17th Dec 202110:07 amRNSDirector/PDMR Shareholding
9th Dec 20219:11 amRNSChanges to Board and Committee Composition
1st Dec 20215:23 pmRNSTotal Voting Rights
30th Nov 20218:58 amRNSIssue of Equity
30th Nov 20217:00 amRNSHalf-year Report
29th Nov 20212:38 pmRNSHalf-year Report
29th Nov 20211:24 pmRNSHalf-year Report
26th Nov 20214:31 pmRNSHolding(s) in Company
25th Nov 20213:47 pmRNSRegulatory Approval
3rd Nov 20214:24 pmRNSDirector/PDMR Shareholding
26th Oct 202110:17 amRNSDirector/PDMR Shareholding
21st Oct 20214:43 pmRNSProposed secondary placing and loan of A shares
19th Oct 202112:05 pmRNSDirector/PDMR Shareholding
19th Oct 20217:00 amRNSQ2 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.